Conference Agenda

  • Registrations And Networking
  • Introduction To Pre – Connect Congress
  • Inauguration And Lamp Lighting
  • Welcome Speech
  • Special Address
  • Chief Guest Address:
    Discussing How Pharmaceutical And Healthcare Sectors Can Be ‘Modified’
    • Highlighting the India Investment Grid benefits – a Government initiative
    • Determining the future of the pharmaceutical industry through three Cs – Cost, Compliance and Competition
    • Removing the road blocks between India and China to ensure more exports of drugs from India
  • Panel Discussion:
    Pharma 4.0 : Embrace Disruption To Avoid Being Disrupted
    • Discussing the future of the pharmaceutical industry
    • Increasing focus connecting human, data and machines
    • Improving quality, productivity and lead times through interconnectivity
    • Growth drivers and opportunities of investment in the pharmaceutical sector in India
    Panel Members:
    • Yugal Sikri, Managing Director, RPG Life Sciences Ltd
    • Vivek Vasudev Kamath, AVP & Managing Director, MSD in India
    • Sanjay Kumar Jain, President - Amneal Pharmaceuticals, India
    • Manoj Saxena, Managing Director, Bayer Zydus Pharma
    • Dr. Sanjit Singh Lamba, Managing Director, Eisai Pharmaceuticals India Pvt Ltd
  • Networking Break
  • Presentation:
    Emerging Trends In Research And Development And Its Impact On The Indian Pharma Industry
    • Dr. Ashok Kumar FRSC, President – Centre for Research & Development, Ipca Laboratories Ltd
  • Lunch and Networking
  • Presentation:
    Challenges and opportunities in peptide drug discovery
    • Designing peptide-based scaffolds
    • Enabling technologies for enhanced analytical characterization in peptide therapeutics discovery and development
    • Novel Technologies For Peptide Delivery
  • Presentation:
    Growth Of Precision Medicines And Importance Of Patience Centricity
    • Focus on increasing diversity in clinical trials
    • Adopting trial designs, adjusting eligibility criteria and improving enrollment practices
    • Ensuring high-quality, personalized patient experience
  • Presentation:
    Recent Innovations In The Medical Devices Industry In India - Getting Easier Or Tougher
    • Impact of digitalization on pharmaceuticals and patient safety
    • Technological innovations in syringes for infusion sets and drug delivery
    • Meeting the regulatory expectations of various markets
  • Presentation:
    Machine Learning (ML) and Artificial Intelligence (AI) in Drug Discovery
    • Utilizing AI and ML to Design Next Generation Compounds
    • Advancements in AI tools to ensure quality in manufacturing
    • Leveraging the power of AI and machine learning by utilizing high-quality big data
    • Identifying the potential to revolutionize the drug discovery and development process
  • Panel Discussion:
    Shifting Focus On Complex Formulations And Portfolio Diversification Of Generics Beyond Vanilla Oral Solids
    • Moving from conventional generics to complex generics and biosimilars
    • Focusing on higher R&D focus for niche products
    • Improved infrastructure and resources for improved surveillance
    • Understanding regulatory expectations
  • Talk Show:
    Identifying The Strength Of Collaborations For Research And Development Of New Products
    • Create new products efficiently
    • Ways to disrupt in target markets
    • Leveraging combined strengths
  • Networking Evening

Brochure

Download

India Pharma 2020 Propelling access and acceptance, realising true potential – McKinsey&Company

Download

Post Show Report 2019

Download
  • Registrations And Networking
  • Introduction To Pre – Connect Congress
  • Inauguration And Lamp Lighting
  • Welcome Speech
  • Special Address
  • Chief Guest Address:
    Discussing How Pharmaceutical And Healthcare Sectors Can Be ‘Modified’
    • Highlighting the India Investment Grid benefits – a Government initiative
    • Determining the future of the pharmaceutical industry through three Cs – Cost, Compliance and Competition
    • Removing the road blocks between India and China to ensure more exports of drugs from India
  • Panel Discussion:
    Pharma 4.0 : Embrace Disruption To Avoid Being Disrupted
    • Discussing the future of the pharmaceutical industry
    • Increasing focus connecting human, data and machines
    • Improving quality, productivity and lead times through interconnectivity
    • Growth drivers and opportunities of investment in the pharmaceutical sector in India
    Panel Members:
    • Yugal Sikri, Managing Director, RPG Life Sciences Ltd
    • Vivek Vasudev Kamath, AVP & Managing Director, MSD in India
    • Sanjay Kumar Jain, President - Amneal Pharmaceuticals, India
    • Manoj Saxena, Managing Director, Bayer Zydus Pharma
    • Dr. Sanjit Singh Lamba, Managing Director, Eisai Pharmaceuticals India Pvt Ltd
  • Networking Break
  • Presentation:
    Emerging Trends In Research And Development And Its Impact On The Indian Pharma Industry
    • Dr. Ashok Kumar FRSC, President – Centre for Research & Development, Ipca Laboratories Ltd
  • Lunch and Networking
  • Presentation:
    Challenges and opportunities in peptide drug discovery
    • Designing peptide-based scaffolds
    • Enabling technologies for enhanced analytical characterization in peptide therapeutics discovery and development
    • Novel Technologies For Peptide Delivery
  • Presentation:
    Growth Of Precision Medicines And Importance Of Patience Centricity
    • Focus on increasing diversity in clinical trials
    • Adopting trial designs, adjusting eligibility criteria and improving enrollment practices
    • Ensuring high-quality, personalized patient experience
  • Presentation:
    Recent Innovations In The Medical Devices Industry In India - Getting Easier Or Tougher
    • Impact of digitalization on pharmaceuticals and patient safety
    • Technological innovations in syringes for infusion sets and drug delivery
    • Meeting the regulatory expectations of various markets
  • Presentation:
    Machine Learning (ML) and Artificial Intelligence (AI) in Drug Discovery
    • Utilizing AI and ML to Design Next Generation Compounds
    • Advancements in AI tools to ensure quality in manufacturing
    • Leveraging the power of AI and machine learning by utilizing high-quality big data
    • Identifying the potential to revolutionize the drug discovery and development process
  • Panel Discussion:
    Shifting Focus On Complex Formulations And Portfolio Diversification Of Generics Beyond Vanilla Oral Solids
    • Moving from conventional generics to complex generics and biosimilars
    • Focusing on higher R&D focus for niche products
    • Improved infrastructure and resources for improved surveillance
    • Understanding regulatory expectations
  • Talk Show:
    Identifying The Strength Of Collaborations For Research And Development Of New Products
    • Create new products efficiently
    • Ways to disrupt in target markets
    • Leveraging combined strengths
  • Networking Evening

Brochure

Download

India Pharma 2020 Propelling access and acceptance, realising true potential – McKinsey&Company

Download

Post Show Report 2019

Download

Copyright © 2019. All rights reserved. Informa Markets, a trading division of Informa PLC.